top of page


UCL is London's leading multidisciplinary university which has a reputation for world-leading neurodegeneration research. The Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology is an internationally recognised centre for clinical neuroscience and translational research. Its research focus combines basic and clinical research for patient benefit, emphasising working synergistically across multiple neurodegenerative diseases. Parkinson’s disease has been one of its main areas of research, and researchers from UCL have been amongst the most highly cited PD researchers worldwide.


Anette Schrag

MD, PhD, Professor of Neurology

Prof. Anette-Eleonore Schrag is Professor of Clinical Neurosciences and Consultant Neurologist in UCL. Her research has focused on clinical aspects of Parkinson’s disease. Her main research has concentrated on the assessment and clinical management of patients with PD, including the psychiatric and other nonmotor aspects of the disease. She has pioneered a patient-centred approach in assessing outcomes of clinical trials in Parkinson’s disease and the inclusion and development of patient-oriented outcome measures in this field. She has worked closely with patient groups, including the European Parkinson’s Disease Association, to improve the experiences of care of patients with Parkinson’s. She has collaborated widely with interdisciplinary groups within the UK and other European countries and is currently the Coordinator of a JPND-funded European project on “Care of Late Stage Parkinsonism”. She has been the PI on a number of treatment trials in this field and is currently PI on three large multi-center studies in the UK, including development and testing a facilitated self-management tool for patients with Parkinson’s disease, conducting a large randomized controlled trial of antidepressants in Parkinson’s disease and identifying risk of Parkinson’s in the general population. She is also collaborating widely on several other clinical trials, including other co-applicant, particularly on the non-motor features of Parkinson’s disease. She has recently published the largest health-economic study of Parkinson’s disease in Europe. She leads the UK Parkinson’s Excellence Network for North London, chairs the Parkinson’s and Movement Disorders Society Task Force on Ratings Scales reviews for Parkinson’s disease, and is a Steering Committee Member of the MDS Non-motor Symptoms Group.

bottom of page